Mylan Products

Difflam Oral Rinse

Difflam Oral Rinse is a locally acting analgesic and anti-inflammatory treatment for the relief of painful inflammatory conditions of the mouth and throat including:1, 3

Treating the pain, soreness, swelling and discomfort of the throat, including pharyngitis.

Traumatic conditions: Pharyngitis following tonsillectomy or the use of a naso-gastric tube

Inflammatory conditions: Pharyngitis, aphthous ulcers and oral ulceration due to radiation therapy

Dentistry: For use after dental operations.

Difflam Oral Rinse can be used as a mouthwash or gargle by adults and children over 12 years1.

Triple Action Relief2:


Anti-inflammatory

To support the body’s natural healing process and help you feel better sooner.


Analgesic

To relieve the pain from a sore throat quickly and effectively.


Anaesthetic

To soothe a sore throat so you can get on with your day.

Do not use Difflam Oral Rinse if you are allergic to benzydamine hydrochloride or any of the other ingredients listed in the Patient Information Leaflet.

Always read the label and patient information leaflet carefully. Do not use for more than seven days continuously unless under advice from a healthcare professional. Avoid contact with eyes. Not suitable for children aged 12 years or under. Keep out of the sight and reach of children.

Always use Difflam Oral Rinse exactly as instructed, and check with a healthcare professional if you are not sure. If symptoms persist, seek further medical advice from your Pharmacist or Doctor.


    References:
  1. Difflam Oral Rinse Summary of Product Characteristics
  2. Agarwal A et al. An evaluation of aspirin and benzydamine hydrochloride gargle for attenuating postoperative sore throat: a prospective sore throat: a prospective, randomized, single-blind study. Anesth Analg 2006; 103(4): 1001-1003.
  3. Difflam Oral Rinse patient information leaflet

Reporting of side effects. If you get side effects, talk to your Doctor or Pharmacist. This includes any possible side effects not listed in the patient information leaflet. You can also report side effects directly via the national reporting system: HPRA Pharmacovigilance, Earlsfort Terrace, IRL – Dublin. Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; E-mail: medsafety@hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine. You should also report any side effects to Mylan Pharmacovigilance on +44(0)8001218267 and Ukpharmacovigilance@mylan.com.